Is Cancer Genetics Inc (CGIX) Going to Burn These Hedge Funds?

We view hedge fund activity in the stock unfavorable, but in this case there was only a single hedge fund selling its entire position: Millennium Management. One hedge fund selling its entire position doesn’t always imply a bearish intent. Theoretically a hedge fund may decide to sell a promising position in order to invest the proceeds in a more promising idea. However, we don’t think this is the case in this case because none of the 700+ hedge funds tracked by Insider Monkey identified CGIX as a viable investment and initiated a position in the stock.

Let’s now review hedge fund activity in other stocks similar to Cancer Genetics Inc (NASDAQ:CGIX). These stocks are Petroquest Energy Inc (NYSE:PQ), Timberland Bancorp, Inc. (NASDAQ:TSBK), Good Times Restaurants Inc. (NASDAQ:GTIM), and Biota Pharmaceuticals Inc (NASDAQ:BOTA). This group of stocks’ market values resemble CGIX’s market value.

As you can see these stocks had an average of 7 hedge funds with bullish positions and the average amount invested in these stocks was $11 million. That figure was just $1 million in CGIX’s case. Petroquest Energy Inc (NYSE:PQ) is the most popular stock in this table, while Timberland Bancorp, Inc. (NASDAQ:TSBK) is the least popular one with only 5 bullish hedge fund positions. Compared to these stocks Cancer Genetics Inc (NASDAQ:CGIX) is even less popular than TSBK. Considering that hedge funds aren’t fond of this stock in relation to other companies analyzed in this article, it may be a good idea to analyze it in detail and understand why the smart money isn’t behind this stock. This isn’t necessarily bad news. Although it is possible that hedge funds may think the stock is overpriced and view the stock as a short candidate, they may not be very familiar with the bullish thesis. In either case more research is warranted.